Close Menu
The Baylor Lariat
    Facebook X (Twitter) Instagram YouTube LinkedIn
    Trending
    • SLIDESHOW: Baylor vs. Texas Tech
    • No. 2 seed Baylor bounces back with 1st round win over Lamar 3-0
    • Baylor’s upset bid fails against No. 4 USC despite hot start
    • No. 20 Baylor volleyball sneaks past Iowa State in gutsy 5-set win
    • Former Baylor Chi Alpha minister pleads no contest to sexual abuse charges
    • Student Senate approves up to $60,000 for Rosenbalm Fountain renovation
    • From wooden bleachers to growing campus, 130 years of Baylor family ties endure
    • Bridging the gap: Why food matters to different cultures
    • About us
      • Fall 2026 Staff Page
      • Copyright Information
    • Contact
      • Contact Information
      • Letters to the Editor
      • Subscribe to The Morning Buzz
      • Department of Student Media
    • Employment
    • PDF Archives
    • RSS Feeds
    Donate
    The Baylor LariatThe Baylor Lariat
    Subscribe to the Morning Buzz
    Saturday, November 21
    • News
      • State and National News
        • State
        • National
      • Politics
        • 2025 Inauguration Page
      • Baylor News
      • Waco Updates
      • Campus and Waco Crime
    • Arts & Life
      • Wedding Edition 2025
      • What to Do in Waco
      • Campus Culture
      • Indy and Belle
      • Leisure and Travel
        • Leisure
        • Travel
          • Baylor in Ireland
      • Student Spotlight
      • Local Scene
        • Small Businesses
        • Social Media
      • Arts and Entertainment
        • Art
        • Fashion
        • Food
        • Literature
        • Music
        • Film and Television
    • Opinion
      • Editorials
      • Points of View
      • Lariat Letters
    • Sports
      • Football
      • Basketball
        • March Madness 2026
        • Men’s Basketball
        • Women’s Basketball
      • Soccer
      • Baseball
      • Softball
      • Volleyball
      • Equestrian
      • Cross Country and Track & Field
      • Acrobatics & Tumbling
      • Tennis
      • Golf
      • Pro Sports
      • Sports Takes
      • Club Sports
    • Lariat TV News
    • Multimedia
      • Video Features
      • Podcasts
        • Don’t Feed the Bears
        • Bear Newscessities
      • Slideshows
      • Online Packages
        • Homecoming 2025
        • Lariat 125
        • Sing 2026
        • Welcome Back 2026
        • 2026 Election
    • Homecoming 2026
    • Advertising
    The Baylor Lariat
    Home»Opinion»Points of View

    Point of View: FDA oversteps bounds when distributing lethal injection drugs from U.K.

    By January 19, 2011Updated:January 19, 2011 Points of View No Comments3 Mins Read
    Share
    Facebook Twitter LinkedIn Pinterest Email

    By Nick Dean
    Editor in Chief

    Our Food and Drug Administration has crossed the line, and entered territory where the organization itself has said it doesn’t belong — executions.

    A public records request filed by the American Civil Liberties Union, a liberal legislative lobbying nonprofit, produced e-mail correspondence between Arizona officials and the FDA discussing the shortage of sodium thiopental — the drug used to put inmates into a sleep prior to execution. The messages prove that the FDA was actively engaged in the execution process for the state of Arizona. One e-mail states that an FDA official wanted a shipment of the drug to “be processed expeditiously to [them] as it was for the purpose of executions and not for use by the general public.” The kicker: the drugs were going to be coming from Britain. (Frankly, I was also shocked an FDA official thought his bureaucracy-filled administration could do anything “expeditiously.” Lest we forget the expedient and error-prone egg farm inspections of August 2010.)

    According to the Associated Press, a federal lawsuit in Arizona “challenges the use of overseas drugs, saying they may be substandard and could lead to botched executions if they do not put an inmate to sleep properly.”

    The FDA official’s recommendation is degrading, improper and simply unjust. A drug “not meant for the general public” is the exact drug that should not be given special, “expeditious” treatment especially if it is being shipped from over seas.

    The ACLU is accusing the FDA of saying one thing and doing another and there is definitely proof. FDA spokesman Christopher Kelly told the Associated Press, “Reviewing substances imported or used for the purpose of state-authorized lethal injection clearly falls outside of FDA’s explicit public health role.” Thanks to the power of the public records request, we now know that is exactly what the FDA has been dealing in — the use of overseas drugs for state-authorized suicide.

    Regardless of the belittling, narrow-mindedness of some, inmates deserve to be treated humanely. Recently, the Supreme Court extended a reprieve to a former Army recruiter six hours before his execution was scheduled. The Supreme Court is reviewing his appeal in which he maintains his innocence surrounding the rape and murder of a Fort Worth woman in 2002.

    The high court properly extended the man his constitutional right to a fair trial. I think the same should be done to those that are being executed. The Constitution does not allow for cruel and unusual punishment. The use of overseas drugs that were not intended for the general public and were only “expeditiously” reviewed by a public health organization not meant to handle these drugs constitutes such unusual — and potentially cruel — punishment.

    This is not to start a debate on the propriety of capital punishment; that is a state decision. The FDA’s involvement with the state of Arizona perfectly illustrates that the federal government is getting involved. The rights of states are clear as is the purpose and role of the FDA. The FDA has no right to negotiate transactions of these drugs and should have never offered the “help” in these e-mails. Concerns of public health are the FDA’s job, and its recent history of major risk lead me to believe we shouldn’t put any more on the agency’s plate.

    Nick Dean is a junior journalism and political science major from Austin and Editor-in-chief of the The Lariat.

    ACLU FDA

    Keep Reading

    Open up your home: Choose connection over convenience

    This Thanksgiving, get niche with your gratitude

    Dyslexia is not a roadblock to success

    An anti-anti-aging look at life: I can’t wait to be an old lady

    Keep the art out of artificial intelligence

    More love, less lust in modern media

    Add A Comment

    Comments are closed.

    Recent Posts
    • SLIDESHOW: Baylor vs. Texas Tech November 21, 2026
    • No. 2 seed Baylor bounces back with 1st round win over Lamar 3-0 November 21, 2026
    About

    The award-winning student newspaper of Baylor University since 1900.

    Articles, photos, and other works by staff of The Baylor Lariat are Copyright © Baylor® University. All rights reserved.

    Subscribe to the Morning Buzz

    Get the latest Lariat News by just Clicking Subscribe!

    Follow the Live Coverage
    Tweets by @bulariat

    Facebook X (Twitter) Instagram YouTube LinkedIn
    • Featured
    • News
    • Sports
    • Opinion
    • Arts and Life
    © 2026 ThemeSphere. Designed by ThemeSphere.

    Type above and press Enter to search. Press Esc to cancel.